Login
Vyne Therapeutics Inc logo

Vyne Therapeutics Inc

vynetherapeutics.com

Vyne Therapeutics Inc (VYNE) is a therapeutics company whose core business activity cannot be fully characterized from the available filing excerpts. The 10-K filed 2026-02-27 (accession 000156604426000002) provides only the cover-page boilerplate of the annual report for the fiscal year ended, with no substantive disclosure of products, revenue streams, pipeline, commercial operations, or financial results in the excerpts provided. Because the filing excerpts do not support specific claims about business model, revenue, products, customers, competitors, or geographic footprint, those details are omitted here in accordance with source-grounding requirements. Investors should consult the full 10-K filing directly for accurate business and financial information.

Financial Snapshot

Revenue
TTM
$499.0K
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$21.47M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
2086.49%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$24.64M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$3.764M

Stock Price

Loading...
Market Cap: $21.13 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support